Brainstorm Cell Therapeutics (BCLI) Stock Chart & Stock Price History $0.72 +0.03 (+4.06%) As of 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Brainstorm Cell Therapeutics Stock Price Performance The Brainstorm Cell Therapeutics (BCLI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 86.92%, with a year-to-date return of -68.37%. In the past month, the stock has decreased 39.15%, reflecting recent market activity. As of the latest close, Brainstorm Cell Therapeutics traded at $0.69 with a market cap of $6.79 million and volume of 59,150 shares. Five years ago, the stock traded at a split-adjusted price of $233.85, representing a 99.69% decrease over that period. At the time, it had a market cap of $458.97 million and a volume of 38,376 shares. Receive BCLI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-16.02%1 Month Performance-39.15%3 Month Performance-26.36%Year-To-Date Performance-68.37%1 Year Performance-86.92%5 Year Performance-99.69% BCLI Stock Chart for Friday, July, 25, 2025 BCLI Chart by TradingView Brainstorm Cell Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$0.69$0.69+0.73%$0.70$0.6659,150 shs$6.79 million07/23/2025$0.68$0.69+1.47%$0.72$0.66182,824 shs$6.74 million07/22/2025$0.75$0.68-9.99%$0.75$0.67379,087 shs$6.64 million07/21/2025$0.86$0.75-12.28%$0.86$0.73413,657 shs$7.38 million07/18/2025$1.17$0.86-26.92%$0.89$0.59819,677 shs$8.41 million07/17/2025$1.20$1.17-2.50%$1.28$1.032.54 million shs$11.81 million07/16/2025$1.20$1.20$1.23$1.18221,786 shs$11.81 million07/15/2025$1.20$1.20$1.22$1.18187,564 shs$11.81 million07/14/2025$1.20$1.20$1.20$1.17172,569 shs$11.81 million07/11/2025$1.22$1.20-1.64%$1.25$1.18250,218 shs$11.81 million Get the Latest News and Ratings for BCLI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025$1.24$1.22-1.61%$1.26$1.18293,168 shs$12.01 million07/09/2025$1.31$1.24-5.34%$1.31$1.23440,111 shs$12.20 million07/08/2025$1.14$1.31+14.91%$1.32$1.152.10 million shs$12.89 million07/07/2025$1.14$1.14$1.19$1.13153,307 shs$11.22 million07/04/2025$1.14$1.14$1.19$1.1498,008 shs$11.22 million07/03/2025$1.17$1.14-2.56%$1.19$1.1498,008 shs$11.22 million07/02/2025$1.11$1.17+5.41%$1.17$1.09269,323 shs$11.51 million07/01/2025$1.12$1.11-0.89%$1.15$1.09212,683 shs$10.92 million06/30/2025$1.06$1.12+5.66%$1.15$1.05245,838 shs$11.02 million06/27/2025$1.09$1.06-2.75%$1.10$1.02419,864 shs$8.42 million06/26/2025$1.18$1.09-7.63%$1.18$1.09365,639 shs$8.65 million06/25/2025$1.23$1.18-4.07%$1.22$1.17207,796 shs$9.37 million06/24/2025$1.19$1.23+3.36%$1.24$1.16381,527 shs$9.77 million Related Companies DYAI Stock Chart SCYX Stock Chart ENLV Stock Chart NRSN Stock Chart GBIO Stock Chart NNVC Stock Chart ALXO Stock Chart QTTB Stock Chart FBLG Stock Chart RANI Stock Chart Receive BCLI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCLI) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainstorm Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
